Evogene (EVGN) Reports Q1 Loss of $0.13/Share

Evogene (NYSE: EVGN) reported Q1 EPS of ($0.13), versus ($0.13) reported last year. Revenue for the quarter came in at $2 million, versus $2.7 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Franklin BSP Realty Trust (FBRT) Reiterated at Market Outperform by Citizens
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance